Search Results 211-220 of 18659 for Parenchyma

  1. Andrew J. Bentall, M.B., Ch.B., M.D.

    Renal parenchymal disease; Renal tubular acidosis; Renovascular disease; Renovascular hypertension; Secondary high blood pressure; Secondary hyperparathyroidism ...

  2. Clinical trials - Oncology (Medical)

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...

  3. Clinical trials - Oncology (Medical)

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...

  4. Clinical trials - Oncology (Medical)

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...

  5. Clinical trials - Oncology (Medical)

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...

  6. Zephyrus II: Effectiveness and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    parenchymal fibrosis (reticulation) and <25% honeycombing. 3. FVCpp ... including diseases of the airways, lung parenchyma, pleural space, mediastinum,

  7. Clinical trials - Oncology (Medical)

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...

  8. Focus areas - Division of Nephrology and Hypertension - Mayo Clinic Research

    Parenchymal and glomerular renal disease. Fernando C. Fervenza, M.D., Ph.D. Dr. Fervenza leads interventional studies aimed at bringing new bench research ...

  9. Clinical trials - Oncology (Medical)

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...

  10. Clinical trials - Oncology (Medical)

    The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...